» Articles » PMID: 28152025

Prevalence of G6PD Deficiency in Selected Populations from Two Previously High Malaria Endemic Areas of Sri Lanka

Overview
Journal PLoS One
Date 2017 Feb 3
PMID 28152025
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Glucose-6-Phosphate Dehydrogenase (G6PD) enzyme deficiency is known to offer protection against malaria and an increased selection of mutant genes in malaria endemic regions is expected. However, anti-malarial drugs such as primaquine can cause haemolytic anaemia in persons with G6PD deficiency. We studied the extent of G6PD deficiency in selected persons attending Teaching Hospitals of Anuradhapura and Kurunegala, two previously high malaria endemic districts in Sri Lanka. A total of 2059 filter-paper blood spots collected between November 2013 and June 2014 were analysed for phenotypic G6PD deficiency using the modified WST-8/1-methoxy PMS method. Each assay was conducted with a set of controls and the colour development assessed visually as well as with a microplate reader at OD450-630nm. Overall, 142/1018 (13.95%) and 83/1041 (7.97%) were G6PD deficient in Anuradhapura and Kurunegala districts respectively. The G6PD prevalence was significantly greater in Anuradhapura when compared to Kurunegala (P<0.0001). Surprisingly, females were equally affected as males in each district: 35/313 (11.18%) males and 107/705 (15.18%) females were affected in Anuradhapura (P = 0.089); 25/313 (7.99%) males and 58/728 (7.97%) females were affected in Kurunegala (P = 0.991). Prevalence was greater among females in Anuradhapura than in Kurunegala (P<0.05), while no such difference was observed between the males (P>0.05). Severe deficiency (<10% normal) was seen among 28/1018 (2.75%) in Anuradhapura (7 males; 21 females) and 17/1041 (1.63%) in Kurunegala (7 males; 10 females). Enzyme activity between 10-30% was observed among 114/1018 (11.20%; 28 males; 86 females) in Anuradhapura while it was 66/1041 (6.34%; 18 males; 48 females) in Kurunegala. Screening and educational programmes for G6PD deficiency are warranted in these high risk areas irrespective of gender for the prevention of disease states related to this condition.

Citing Articles

Remedy or tragedy: -induced acute oxidative hemolysis associated with acute kidney injury and infective endocarditis: An initial presentation of G6PD Deficiency: A case report.

Charles J, Kiriwandeniya K, Liyanapathirana K, Gunarathna R, Mendis S, Liyanarachchi G SAGE Open Med Case Rep. 2024; 12:2050313X241266554.

PMID: 39071198 PMC: 11282534. DOI: 10.1177/2050313X241266554.


Acalypha indica induced acute oxidative haemolysis and methaemoglobinaemia: two case reports.

Maddumabandara K, Rajaratnam A, Ishfak M, Samarakoon N, Ellepola K, Bowattage S J Med Case Rep. 2024; 18(1):163.

PMID: 38500232 PMC: 10949590. DOI: 10.1186/s13256-024-04481-8.


Plasmodium ovale infection in Sri Lanka: distant exposure and incidental detection of hyperparasitemia: a case report.

Kularatne D, Chulasiri P, Dharmapala A, Kularatne S J Med Case Rep. 2023; 17(1):509.

PMID: 38082342 PMC: 10714539. DOI: 10.1186/s13256-023-04226-z.


G6PDH as a key immunometabolic and redox trigger in arthropods.

Moraes B, Martins R, Lopes C, Martins R, Arcanjo A, Nascimento J Front Physiol. 2023; 14:1287090.

PMID: 38046951 PMC: 10693429. DOI: 10.3389/fphys.2023.1287090.


Prevalence of G6PD deficiency and distribution of its genetic variants among malaria-suspected patients visiting Metehara health centre, Eastern Ethiopia.

Shenkutie T, Nega D, Hailu A, Kepple D, Witherspoon L, Lo E Malar J. 2022; 21(1):260.

PMID: 36076204 PMC: 9461287. DOI: 10.1186/s12936-022-04269-5.


References
1.
Dewasurendra R, Rockett K, Fernando S, Carter R, Kwiatkowski D, Karunaweera N . G6PD gene variants and its association with malaria in a Sri Lankan population. Malar J. 2015; 14:93. PMC: 4343272. DOI: 10.1186/s12936-015-0603-9. View

2.
Shanks G, Oloo A, Aleman G, Ohrt C, Klotz F, Braitman D . A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. Clin Infect Dis. 2001; 33(12):1968-74. DOI: 10.1086/324081. View

3.
Nkhoma E, Poole C, Vannappagari V, Hall S, Beutler E . The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009; 42(3):267-78. DOI: 10.1016/j.bcmd.2008.12.005. View

4.
Denic S, Nicholls M . Genetic benefits of consanguinity through selection of genotypes protective against malaria. Hum Biol. 2007; 79(2):145-58. DOI: 10.1353/hub.2007.0030. View

5.
Martini G, Toniolo D, Vulliamy T, Luzzatto L, Dono R, Viglietto G . Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase. EMBO J. 1986; 5(8):1849-55. PMC: 1167050. DOI: 10.1002/j.1460-2075.1986.tb04436.x. View